Sep 8, 2021
Vancouver, Canada, and Frankfurt, Germany (September 08, 2021) - XPhyto Therapeutics Corp. (CSE:XPHY / OTC:XPHYF / FSE:4XT) (“XPhyto” or the “Company”) is pleased to announce...
Aug 30, 2021
Biosensor test dissolves on the tongue and turns bitter indicating the presence of oral inflammation after five minutesEasy and simple at-home self-checks improve oral health...
Jul 28, 2021
First saliva activated biosensor molecules identified to diagnose COVID-19 infection using XPhyto’s oral dissolvable delivery platformBiosensor candidates are ready for optimization and performance assessmentDevelopment of...
Jul 20, 2021
The acquisition creates significant commercial development and manufacturing opportunities for XPhyto as well as cost synergies and improved margins on its diagnostic products.The acquisition secures...
Jun 30, 2021
XPhyto signs master supply agreement with operator of 10 COVID-19 test centersThe test will be offered to customers as a rapid PCR test with sample...
Jun 8, 2021
Research and development lab set up, preliminary mescaline synthesis completeModified synthesis process developed, mescaline batches manufacturedDevelopment of analytical methods and validation, GMP standard operating procedures...
May 20, 2021
Rapid 25-minute point-of-care COVID-19 PCR test available for purchase in Germany commencing May 25, 2021Volume based pricing competitive with other COVID-19 PCR test products on...
May 13, 2021
Rotigotine transdermal human pilot study successfully completed; program advancing to pivotal studyLand purchased for construction of commercial drug manufacturing facility in Germany Vancouver, Canada, and...
May 7, 2021
Pilot project includes point-of-care sample collection, PCR processing and final testing of workflow logisticsProject is in cooperation with a German pharmacy currently running a COVID-19...
Apr 28, 2021
XPhyto delivered 2,000 of its 25-minute PCR tests to Israeli distributor for clinical evaluation and regulatory approval. Potential customers include government institutions, private healthcare providers...
Apr 21, 2021
XPhyto has entered into an agreement with an established German pharmaceutical wholesaler and service provider for the distribution, storage and logistics of XPhyto's diagnostic products...
Apr 20, 2021
XPhyto announces the appointment of Mr. Wolfgang Probst as the Chief Operations Officer (COO) of XPhyto and the addition of Mr. Manfred Buchberger as the...
Hear about our latest research, products, exclusive partnerships & more.